Tirzepatide is a dual GIP and GLP-1 receptor agonist developed to target multiple metabolic pathways simultaneously. Its unique mechanism makes it a cornerstone compound in modern metabolic and glycemic control protocols.
Each unit is protected with anti-counterfeit measures and produced in accordance with rigorous quality standards, suitable for clinical, research, and advanced wellness applications.
Key features
- Dual GIP / GLP-1 receptor agonist
- Controlled pen delivery
- Secure, authenticated packaging
- Professional-grade formulation
